ConscriptsPrENTNCT06105346
Prevalence of ENT Diseseas
An observational study of Conscripts and Military Induction Board, run by Medical University of Graz.
Trial summary
The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand… Read more about this study
- Who is it for?
- Ages 17 to 19 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Conscripts, Military Induction Board, ENT Disease
- How many people
- 10,000 participants
- Where
- No sites listed yet
- Study dates
- 1 Dec 2023to 31 Mar 2026
- How long will I take part?
- 1 Week
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 to 19 years
- Men only
- Healthy volunteers accepted
- Child, Adult
Study population: All male Austrian conscripts who take part at the military inductions board are eligible for the study inclusion.
Who may be able to join
- participation of the military induction board of conscripts
- consent for participation obtained by the conscripts
- completed questionnaire (with at least 50% completeness of each subcategory)
- participation of medical examination
Who cannot join
- no consent for participation in the study by the conscripts
- incomplete questionnaire (with less than 50% completeness of each subcategory)
- no participation of medical examination.
Trial locations and contacts
No sites are listed yet.
Reinhard Domanyi, MD contact
About this study
Official title: Prevalence Study of ENT-related Diseases in Conscripts at the Military Induction Board
The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.
Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.
Read the detailed description
Rhinosinusitis is a very common complaint at ENT departments, whereby symptoms of the underlying disease are varying. Therefore, there is growing interest in prevalence of rhinosinusitis including differences in prevalence's depending on where the patient grew up. Further, there is growing interest in answering the question if different factors, including ENT-surgeries in medical history have an impact on symptoms of rhinosinusitis.
Within the past few years there is growing interest in carring out as many HPV-vaccinations as possible in order to reduce the prevalence of HPV-associated cancers.
Further, in adolescents there is a growing number of hearing impairments, including hearing loss and/or sounds in the ears.
Next, since the beginning of the COVID pandemic there are very common complaints in adult and pediatric patients about persistent medical problems for weeks or months after an acute SARS-CoV-2-infection and cannot be explained by another diagnosis, called long- Covid disease.
The military induction board of conscripts enables access to data from a cross-section of the population, with common characteristics of gender and age.
In the present study we want therefore to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.
- Conditions
- Conscripts, Military Induction Board, ENT Disease, Rhinosinusitis Chronic, Rhinosinusitis, HPV Infection
- Keywords
- ENT, prevalence, military induction board, conscripts, rhinosinusitis, Long COVID, ENT surgeries, HPV vaccination, inborn hearing loss
- Medical subject headings
- Otorhinolaryngologic Diseases, Rhinosinusitis, Papillomavirus Infections, Post-Acute COVID-19 Syndrome
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of rhinosinusitis
To assess whether there is a difference in prevalence of rhinosinusitis in urban-bred conscripts compared to non-urban-bred conscripts.
Measured: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccination
To assess whether there is a difference in prevalence of human papilloma virus vaccinations in urban-bred conscripts compared to non-urban-bred conscripts.
Measured: Through data collection, an average of 1 week
Prevalence of hearing impairment
To assess whether there is a difference in prevalence of hearing impairment in urban-bred conscripts compared to non-urban-bred conscripts.
Measured: Through data collection, an average of 1 week
Prevalence of long-COVID disease
To assess whether there is a difference in prevalence of long-COVID disease in vaccinated conscripts compared to no-vaccinated conscripts.
Measured: Through data collection, an average of 1 week
Secondary outcomes (16)
Prevalence of rhinosinusitis
To assess prevalence of rhinosinusitis in conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the different symptoms of rhinosinusitis in conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the prevalence of rhinosinusitis in conscripts with previous ENT-surgeries
Measured: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess differences in symptoms in rhinosinusitis in conscripts with previous ENT-surgeries
Measured: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the combined prevalence of rhinosinusitis and chronic pulmonary diseases in conscripts
Measured: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the difference in prevalence of subjective symptoms of rhinosinusitis compared to objective (apparatus based and laboratory based) symptoms of rhinosinusitis
Measured: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To analyse demographic data in conscripts with rhinosinusitis
Measured: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccines
To assess the prevalence of HPV vaccines among conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccines
To assess knowledge about HPV and HPV vaccinations and in dependent of that prevalence of HPV vaccines among conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of hearing impairment
To assess the prevalence of hearing impairment in conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of hearing impairment
To assess the difference in prevalence of subjective symptoms of hearing impairment compared to objective (apparatus based and laboratory based) signs of hearing impairment
Measured: Through data collection, an average of 1 week
Prevalence of hearing impairment
To analyse demographic data in conscripts with hearing impairment
Measured: Through data collection, an average of 1 week
Prevalence of long-COVID
To assess the prevalence of long-COVID in conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of long-COVID
To assess different symptoms of long-COVID in conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of COVID-19 infection
To assess the prevalence of previous COVID 19 infections in conscripts at the military induction board
Measured: Through data collection, an average of 1 week
Prevalence of long-COVID
To analyse demographic data in conscripts with long-COVID
Measured: Through data collection, an average of 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Oct 2023
- Study start1 Dec 2023 (estimated)
- Primary completion1 Dec 2025 (estimated)
- Study completion31 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ConscriptsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10,000 participants (estimated)
- Target duration
- 1 Week
Sponsor and investigators
- Lead sponsor
- Medical University of Graz
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06105346
- Sponsor's protocol ID
- PrENT v1
- Acronym
- PrENT
- Status last verified
- Oct 2023
- First submitted
- 9 Oct 2023
- Last updated
- 27 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence Study of ENT-related Diseases in Conscripts at the Military Induction Board
- ClinicalTrials.gov ID
- NCT06105346
- Acronym / sponsor ID
- PrENT / PrENT v1
- Conditions
- Conscripts, Military Induction Board, ENT Disease, Rhinosinusitis Chronic, Rhinosinusitis, HPV Infection
- Keywords
- ENT, prevalence, military induction board, conscripts, rhinosinusitis, Long COVID, ENT surgeries, HPV vaccination
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- Medical University of GrazUniversity, hospital or other
- Study start
- 1 Dec 2023 (estimated)
- Primary completion
- 1 Dec 2025 (estimated)
- Study completion
- 31 Mar 2026 (estimated)
- First posted
- 27 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.
Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.
Detailed description
Rhinosinusitis is a very common complaint at ENT departments, whereby symptoms of the underlying disease are varying. Therefore, there is growing interest in prevalence of rhinosinusitis including differences in prevalence's depending on where the patient grew up. Further, there is growing interest in answering the question if different factors, including ENT-surgeries in medical history have an impact on symptoms of rhinosinusitis.
Within the past few years there is growing interest in carring out as many HPV-vaccinations as possible in order to reduce the prevalence of HPV-associated cancers.
Further, in adolescents there is a growing number of hearing impairments, including hearing loss and/or sounds in the ears.
Next, since the beginning of the COVID pandemic there are very common complaints in adult and pediatric patients about persistent medical problems for weeks or months after an acute SARS-CoV-2-infection and cannot be explained by another diagnosis, called long- Covid disease.
The military induction board of conscripts enables access to data from a cross-section of the population, with common characteristics of gender and age.
In the present study we want therefore to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Week
Who may qualify
- Ages
- 17 to 19 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- All male Austrian conscripts who take part at the military inductions board are eligible for the study inclusion.
Key inclusion criteria (4 listed)
- participation of the military induction board of conscripts
- consent for participation obtained by the conscripts
- completed questionnaire (with at least 50% completeness of each subcategory)
- participation of medical examination
Key exclusion criteria (3 listed)
- no consent for participation in the study by the conscripts
- incomplete questionnaire (with less than 50% completeness of each subcategory)
- no participation of medical examination.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
To assess whether there is a difference in prevalence of rhinosinusitis in urban-bred conscripts compared to non-urban-bred conscripts.
Prevalence of human papilloma virus vaccination
Time frame: Through data collection, an average of 1 week
To assess whether there is a difference in prevalence of human papilloma virus vaccinations in urban-bred conscripts compared to non-urban-bred conscripts.
Prevalence of hearing impairment
Time frame: Through data collection, an average of 1 week
To assess whether there is a difference in prevalence of hearing impairment in urban-bred conscripts compared to non-urban-bred conscripts.
Prevalence of long-COVID disease
Time frame: Through data collection, an average of 1 week
To assess whether there is a difference in prevalence of long-COVID disease in vaccinated conscripts compared to no-vaccinated conscripts.
16 secondary outcomes
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccines
Time frame: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccines
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID
Time frame: Through data collection, an average of 1 week
Prevalence of COVID-19 infection
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID
Time frame: Through data collection, an average of 1 week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2023.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Reinhard Domanyi, MD contact
Questions about this trial
What is this clinical trial studying?
An observational study of Conscripts and Military Induction Board, run by Medical University of Graz.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 27 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Emanuel Maitz, MD (00436604756105, emanuel.maitz@medunigraz.at), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of rhinosinusitis (time frame: Through data collection, an average of 1 week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2023.